Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors
Not Applicable
Completed
- Conditions
- Insomnia
- Interventions
- Other: Questionnaires
- Registration Number
- NCT03981666
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Brief Summary
SLEEP-4-ALL-1 is a pilot and ecological study corresponding to the developpement phase of a randomized controlled multicentric trial SLEEP-4-ALL-2. The main objective of this second study will be the validation of a stepped-care model in the treatment of persistant insomnia in cancer patients.
The primary objective of SLEEP-4-ALL-1 is to determine the acceptability of a self-screening for insomnia in cancer outpatients at Gustave Roussy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 177
Inclusion Criteria
- Adults outpatients at Gustave Roussy,
- with a breast, colorectal, pulmonary or urological,
- localized or metastatic cancer,
- during or after their treatment,
- able to readily read and understand French,
- able to use informatic tools confidently and with Internet access at home,
- who have signed a written informed consent form prior to any study specific procedures,
- affiliated to a social security system or beneficiary of the same.
Exclusion Criteria
- Age > 85 years old,
- patient receiving a cancer diagnostic during a consultation of announcement
- with a WHO index of 3 or 4
- severe cognitive impairements or psychiatric disorders which are incompatible with the conditions and the conduct of the study (understanding of the objectives, completion of the questionnaires)
- simultaneous participation in another study of the same type
- patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patients with insomnia Questionnaires adult outpatients with a localized or metastatic breast, colorectal, pulmonary or urological cancer
- Primary Outcome Measures
Name Time Method Acceptance rate of self-screening for insomnia Up to 8 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Gustave Roussy
🇫🇷Villejuif, Val De Marne, France